{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:10:20Z","timestamp":1788801020341,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-63671-0","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:54:59Z","timestamp":1784962499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated network pharmacology, molecular docking, and experimental validation to reveal the potential mechanism of Ginsenoside Rg1 on chronic obstructive pulmonary disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Xinpeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5586-4088","authenticated-orcid":false,"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"63671_CR1","doi-asserted-by":"publisher","first-page":"2002104","DOI":"10.1183\/13993003.02104-2020","volume":"56","author":"A Agusti","year":"2020","unstructured":"Agusti, A. et al. Time for a change: anticipating the diagnosis and treatment of COPD. Eur. Respir J. 56, 2002104 (2020).","journal-title":"Eur. Respir J."},{"key":"63671_CR2","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","volume":"204","author":"BR Celli","year":"2021","unstructured":"Celli, B. R. et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: The Rome proposal. Am. J. Respir. Crit. Care Med. 204, 1251\u20131258 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"63671_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1164\/rccm.202204-0671PP","volume":"206","author":"B Celli","year":"2022","unstructured":"Celli, B. et al. Definition and nomenclature of chronic obstructive pulmonary disease: Time for its revision. Am. J. Respir Crit. Care Med. 206, 1317\u20131325 (2022).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"63671_CR4","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.rmed.2020.105938","volume":"166","author":"CF Vogelmeier","year":"2020","unstructured":"Vogelmeier, C. F. et al. Goals of COPD treatment: focus on symptoms and exacerbations. Respir Med. 166, 105938 (2020).","journal-title":"Respir Med."},{"key":"63671_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-020-00345-x","volume":"5","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Progress in the mechanism and targeted drug therapy for COPD. Signal. Transduct. Target. Ther. 5, 248 (2020a).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"63671_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0075-2021","volume":"30","author":"M Miravitlles","year":"2021","unstructured":"Miravitlles, M. et al. Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. Eur. Respir. Rev. 30, 210075 (2021).","journal-title":"Eur. Respir. Rev."},{"key":"63671_CR7","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/ptr.6605","volume":"34","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Antimicrobial activities of Asian ginseng, American ginseng, and notoginseng. Phytother. Res. 34, 1226\u20131236 (2020).","journal-title":"Phytother. Res."},{"key":"63671_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1179705","volume":"14","author":"Q Xie","year":"2023","unstructured":"Xie, Q. et al. Antioxidant and anti- inflammatory properties of ginsenoside Rg1 for hyperglycemia in type 2 diabetes mellitus: Systematic reviews and meta-analyses of animal studies. Front. Pharmacol. 14, 1179705 (2023).","journal-title":"Front. Pharmacol."},{"key":"63671_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/JLB.1A0422-211R","volume":"112","author":"J Guo","year":"2022","unstructured":"Guo, J., Wang, R. & Min, F. Ginsenoside Rg1 ameliorates sepsis-induced acute kidneyinjury by inhibiting ferroptosis in renal tubular epithelial cells. J. Leukoc. Biol. 112, 1065\u20131077 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"63671_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114920","volume":"164","author":"BL Tang","year":"2023","unstructured":"Tang, B. L., Liu, Y., Zhang, J. L., Lu, M. L. & Wang, H. X. Ginsenoside Rg1 ameliorateshypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-tomesenchymal transition and inflammation by regulating CCN1. Biomed. Pharmacother. 164, 114920 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"63671_CR11","first-page":"2022","volume":"1244836","author":"P. Chen","year":"2022","unstructured":"Chen, P. . et al. Ginsenoside Rg1 suppresses non- small-cell lungcancer via MicroRNA-126-PI3K-AKT-mTOR pathway. Evid Based Comp. Alternat.Med. 1244836, 2022 (2022).","journal-title":"Evid Based Comp. Alternat.Med."},{"key":"63671_CR12","first-page":"6453296","volume":"2019","author":"QL Wang","year":"2019","unstructured":"Wang, Q. L. et al. Ginsenoside Rg1 regulates SIRT1 to amelioratesepsis-induced lung inflammation and injury via inhibiting endoplasmic reticulumstress and inflammation. Mediat. Inflamm. 2019, 6453296 (2019).","journal-title":"Mediat. Inflamm."},{"key":"63671_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/09645284221107684","volume":"41","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Dopamine relieves inflammatory responses through the D2 receptor after electroacupuncture at ST36 in a mouse model of chronic obstructive pulmonary disease. Acupunct. Med. 41, 163\u2013174 (2023).","journal-title":"Acupunct. Med."},{"key":"63671_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1474870","volume":"11","author":"T Feng","year":"2024","unstructured":"Feng, T. et al. Animal models of chronic obstructive pulmonary disease: A systematic review. Front. Med. (Lausanne) 11, 1474870 (2024).","journal-title":"Front. Med. (Lausanne)"},{"key":"63671_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105923","volume":"26","author":"N Li","year":"2023","unstructured":"Li, N. et al. Streptococcus pneumoniae promotes lung cancer development and progression. iScience 26, 105923 (2023).","journal-title":"iScience"},{"key":"63671_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/07388551.2019.1709797","volume":"40","author":"A Basauri","year":"2020","unstructured":"Basauri, A. et al. Biochemical interactions between LPS and LPS-binding molecules. Crit. Rev. Biotechnol. 40, 292\u2013305 (2020).","journal-title":"Crit. Rev. Biotechnol."},{"key":"63671_CR17","doi-asserted-by":"publisher","first-page":"112122","DOI":"10.1016\/j.jep.2019.112122","volume":"243","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. The protection of indolealkylamines from LPS- induced inflammation in zebrafish. J. Ethnopharmacol. 243, 112122 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"63671_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/gutjnl-2020-322599","volume":"71","author":"HC Lai","year":"2022","unstructured":"Lai, H. C. et al. Gut microbiota modulates COPD pathogenesis: Role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide. Gut 71, 309\u2013321 (2022).","journal-title":"Gut"},{"key":"63671_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/COPD.S449521","volume":"19","author":"L Lu","year":"2024","unstructured":"Lu, L. et al. Therapeutic effects of Lifei decoction in a murine model of COPD induced by LPS and cigarette smoke. Int. J. Chron. Obstruct Pulmon Dis. 19, 957\u2013967 (2024).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"63671_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108926","volume":"110","author":"X Han","year":"2022","unstructured":"Han, X. et al. Protective effects and possible mechanism of 6-gingerol against arsenic trioxide-induced nephrotoxicity based on network pharmacological analysis and experimental validation. Int. Immunopharmacol. 110, 108926 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"63671_CR21","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim, S. et al. PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Res. 49, D1388\u2013d1395 (2021).","journal-title":"Nucleic Acids Res."},{"key":"63671_CR22","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357-w364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"63671_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinform. 54, 1\u201330 (2016).","journal-title":"Curr. Protoc. Bioinform."},{"key":"63671_CR24","doi-asserted-by":"publisher","first-page":"1.2.1","DOI":"10.1002\/cpbi.27","volume":"58","author":"JS Amberger","year":"2017","unstructured":"Amberger, J. S. & Hamosh, A. Searching online Mendelian inheritance in man (OMIM): A knowledgebase of human genes and genetic phenotypes. Curr. Protoc. Bioinformatics 58, 1.2.1-1.2.12 (2017).","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"D1","key":"63671_CR25","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638\u2013d646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"63671_CR26","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"63671_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115105","volume":"165","author":"HJ Song","year":"2023","unstructured":"Song, H. J. et al. Cryptotanshinone alleviates lipopolysaccharide and cigarette smoke-induced chronic obstructive pulmonary disease in mice via the Keap1\/Nrf2 axis. Biomed. Pharmacother. 165, 115105 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"63671_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-024-00837-6","volume":"24","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Polyphyllin B inhibited STAT3\/NCOA4 pathway and restored gut microbiota to ameliorate lung tissue injury in cigarette smoke-induced mice. BMC Biotechnol. 24, 13 (2024).","journal-title":"BMC Biotechnol."},{"key":"63671_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70253","volume":"39","author":"R Qi","year":"2025","unstructured":"Qi, R. & Fei, Y. W. Auraptene mitigates cigarette smoke and lipopolysaccharide-induced chronic obstructive pulmonary disease in mice and BEAS-2B cells via regulating Keap1\/Nrf2\/ HO-1 pathway. J. Biochem. Mol. Toxicol. 39, e70253 (2025).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"63671_CR30","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/ijms17071141","volume":"17","author":"J Gao","year":"2016","unstructured":"Gao, J. et al. Ligand and structure-based approaches for the identification of peptide deformylase inhibitors as antibacterial drugs. Int. J. Mol. Sci. 17, 1141 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"63671_CR31","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.2147\/COPD.S170555","volume":"13","author":"J Ma","year":"2018","unstructured":"Ma, J. et al. Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study. Int. J. Chron. Obstruct Pulmon Dis. 13, 3107\u20133114 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"63671_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154057","volume":"100","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Treatment with JianPiYiFei II granules for patients with moderate to very severe chronic obstructive pulmonary disease: A 52-week randomised, double-blinded, placebo-controlled, multicentre trial. Phytomedicine 100, 154057 (2022).","journal-title":"Phytomedicine"},{"key":"63671_CR33","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2147\/COPD.S413754","volume":"18","author":"XQ Yu","year":"2023","unstructured":"Yu, X. Q. et al. Bu-Fei Yi-Shen granules reduce acute exacerbations in patients with GOLD 3\u20134 COPD: a randomized controlled trial. Int. J. Chron. Obstruct Pulmon Dis. 18, 2439\u20132456 (2023).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"63671_CR34","doi-asserted-by":"publisher","first-page":"116229","DOI":"10.1016\/j.jep.2023.116229","volume":"307","author":"X Cao","year":"2023","unstructured":"Cao, X. et al. Advances in traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease. J. Ethnopharmacol. 307, 116229 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"63671_CR35","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2147\/COPD.S81032","volume":"10","author":"MQ Mahmood","year":"2015","unstructured":"Mahmood, M. Q. et al. Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction. Int. J. Chron. Obstruct Pulmon Dis. 10, 1515\u20131524 (2015).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"issue":"3","key":"63671_CR36","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1124\/jpet.110.168518","volume":"334","author":"H Jiang","year":"2010","unstructured":"Jiang, H. et al. Phosphoinositide 3-kinase gamma regulates airway smooth muscle contraction by modulating calcium oscillations. J. Pharmacol. Exp. Ther. 334 (3), 703\u2013709 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"63671_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales, C. et al. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol. Sci. 43, 136\u2013150 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"63671_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118644","volume":"276","author":"T Li","year":"2022","unstructured":"Li, T., Guo, R., Zong, Q. & Ling, G. Application of molecular docking in elaborating molecular mechanisms and interactions of supramolecular cyclodextrin. Carbohydr. Polym. 276, 118644 (2022).","journal-title":"Carbohydr. Polym."},{"key":"63671_CR39","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1172\/JCI32278","volume":"117","author":"H Zhang","year":"2007","unstructured":"Zhang, H. et al. ErbB receptors: from oncogenes to targeted cancer therapies. J. Clin. Invest. 117, 2051\u20132058 (2007).","journal-title":"J. Clin. Invest."},{"key":"63671_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2, 127\u2013137 (2001).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"63671_CR41","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/1878-0261.70069","volume":"19","author":"EG Paiva","year":"2025","unstructured":"Paiva, E. G. et al. EGFR-STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1- positive prostate cancer. Mol. Oncol. 19, 3287\u20133304 (2025).","journal-title":"Mol. Oncol."},{"key":"63671_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/JOE-19-0058","volume":"242","author":"W Luo","year":"2019","unstructured":"Luo, W. et al. Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes. J. Endocrinol. 242, 199\u2013210 (2019).","journal-title":"J. Endocrinol."},{"key":"63671_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4149\/neo_2025_241017N421","volume":"72","author":"X Ke","year":"2025","unstructured":"Ke, X., Li, L., Yan, Q., Wang, X. & Liu, P. EGFR\/STAT3 signaling mediates the upregulation of CD47 in HPV-positive cervical cancer by activating p65 and exosome transporter RAB31. Neoplasma 72, 59\u201366 (2025).","journal-title":"Neoplasma"},{"key":"63671_CR44","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1183\/09031936.00172007","volume":"32","author":"PR Burgel","year":"2008","unstructured":"Burgel, P. R. & Nadel, J. A. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur. Respir. J. 32, 1068\u20131081 (2008).","journal-title":"Eur. Respir. J."},{"key":"63671_CR45","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1172\/JCI0215786","volume":"109","author":"AB Pernis","year":"2002","unstructured":"Pernis, A. B. & Rothman, P. B. JAK-STAT signaling in asthma. J. Clin. Invest. 109, 1279\u20131283 (2002).","journal-title":"J. Clin. Invest."},{"key":"63671_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000497072","volume":"12","author":"A Dakhama","year":"2020","unstructured":"Dakhama, A. et al. Tollip inhibits ST2 signaling in airway epithelial cells exposed to type 2 cytokines and rhinovirus. J. Innate Immun. 12, 103\u2013115 (2020).","journal-title":"J. Innate Immun."},{"key":"63671_CR47","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.4049\/jimmunol.1901227","volume":"204","author":"D Francisco","year":"2020","unstructured":"Francisco, D. et al. Surfactant protein-A protects against IL-13-induced inflammation in asthma. J. Immunol. 204, 2829\u20132839 (2020).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63671-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63671-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63671-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:03:16Z","timestamp":1788800596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63671-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63671"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63671-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27975"}}